HORIZON PHARMA INVESTMENT LIMITED, as Issuer HORIZON PHARMA PUBLIC LIMITED COMPANY, as Guarantor AND U.S. BANK NATIONAL ASSOCIATION, as Trustee Indenture Dated as of March 13, 2015 2.50% Exchangeable Senior Notes due 2022Horizon Pharma PLC • March 13th, 2015 • Pharmaceutical preparations • New York
INDENTURE, dated as of March 13, 2015 by and among Horizon Pharma Investment Limited, a Bermuda exempted company limited by shares, as Issuer (as more fully set forth in Section 1.01, the “Issuer”), Horizon Pharma Public Limited Company, a public limited company formed under the laws of Ireland, as Guarantor (as more fully set forth in Section 1.01, the “Guarantor”), and U.S. Bank National Association, a national banking association, as Trustee (as more fully set forth in Section 1.01, the “Trustee”).
